Haemonetics (HAE) Research & Development (2016 - 2025)
Historic Research & Development for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $14.2 million.
- Haemonetics' Research & Development fell 1037.34% to $14.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $63.6 million, marking a year-over-year increase of 555.96%. This contributed to the annual value of $62.7 million for FY2025, which is 1522.37% up from last year.
- According to the latest figures from Q4 2025, Haemonetics' Research & Development is $14.2 million, which was down 1037.34% from $14.9 million recorded in Q3 2025.
- Haemonetics' Research & Development's 5-year high stood at $18.3 million during Q1 2025, with a 5-year trough of $10.0 million in Q1 2022.
- In the last 5 years, Haemonetics' Research & Development had a median value of $13.2 million in 2022 and averaged $13.5 million.
- Per our database at Business Quant, Haemonetics' Research & Development surged by 6388.39% in 2021 and then tumbled by 1416.42% in 2022.
- Over the past 5 years, Haemonetics' Research & Development (Quarter) stood at $10.9 million in 2021, then rose by 16.92% to $12.7 million in 2022, then rose by 4.54% to $13.3 million in 2023, then rose by 19.33% to $15.8 million in 2024, then dropped by 10.37% to $14.2 million in 2025.
- Its last three reported values are $14.2 million in Q4 2025, $14.9 million for Q3 2025, and $16.3 million during Q2 2025.